Stay updated with breaking news from Fabio fiallo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ARCA biopharma, Inc. (NASDAQ:ABIO – Get Free Report) saw some unusual options trading activity on Wednesday. Stock traders acquired 3,817 call options on the company. This is an increase of 10,216% compared to the typical daily volume of 37 call options. Institutional Trading of ARCA biopharma Hedge funds have recently added to or reduced their […] ....
Newtyn Management LLC reduced its holdings in shares of ARCA biopharma, Inc. (NASDAQ:ABIO – Free Report) by 4.2% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 300,000 shares of the biopharmaceutical company’s stock after selling 13,200 shares during the quarter. Newtyn Management LLC’s […] ....
Equities researchers at StockNews.com initiated coverage on shares of ARCA biopharma (NASDAQ:ABIO – Get Free Report) in a report released on Friday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. ARCA biopharma Trading Up 1.2 % ABIO opened at $1.67 on Friday. The firm has a market cap of $24.22 million, a […] ....
ARCA biopharma, Inc. (NASDAQ:ABIO – Get Free Report) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $1.88 and traded as low as $1.58. ARCA biopharma shares last traded at $1.60, with a volume of 17,434 shares. Wall Street Analyst Weigh In Separately, StockNews.com started […] ....